xCystence Bio
PrivateLast Round
Pre Seed
Mar 30, 2026
Total Funding Raised
$500,000
Company Overview
xCystence Bio operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a Pre Seed round in March 2026.
xCystence Bio is a biotechnology company developing targeted protein degraders to treat Autosomal Dominant Polycystic Kidney Disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
xCystence Bio Comparables
Compare xCystence Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mironid | 79% | |
| Eli Lilly and Company | 70% | |
| Novartis | 66% |
For institutional investors. Book with your work email.
xCystence Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 30, 2026 | ||||
| Grant | Sep 4, 2025 | ||||
| Grant | May 30, 2023 |
For institutional investors. Book with your work email.
xCystence Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CUREator | Grant |
| BioCurate | Pre Seed |
| Monash Investment Holdings | Pre Seed |
| Uniseed | Pre Seed |
| Breakthrough Victoria | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 30, 2023
$330K grant received from CUREator.
For institutional investors. Book with your work email.
xCystence Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about xCystence Bio's valuation, stock price, and market status.
Is xCystence Bio a public or private company?
xCystence Bio is a private company.
What is the current stock price of xCystence Bio?
xCystence Bio is a private company, so its shares have no public market price. Caplight tracks xCystence Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is xCystence Bio worth (valuation)?
Valuation information for xCystence Bio is not publicly available.
Can I buy xCystence Bio stock?
xCystence Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was xCystence Bio's last funding round?
xCystence Bio's most recent funding round was Pre Seed on March 30, 2026.
Who are the main investors in xCystence Bio?
Key investors in xCystence Bio include Uniseed.
Will xCystence Bio IPO soon?
No public IPO plans have been announced for xCystence Bio.
How can I track xCystence Bio secondary market activity?
Caplight tracks bids, offers, and trades in xCystence Bio's shares on secondary markets.